Page 3 - Wild Type News Today

Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The

Afreen Shariff, MD, MBBS, examines the surveillance and management of immunotherapy-induced adrenal insufficiency in the context of melanoma, underscoring the importance of maintaining a heightened awareness for early detection.

A panel of oncology experts explores the intricate balance between maintaining quality of life and managing toxicity in adjuvant immunotherapy for melanoma.

Afreen Shariff, MD introduces case 1 involving a 55-year-old male with Stage IIIB melanoma who develops immunotherapy-induced diabetes.

Nikhil Khushalani, MD, examines immunotherapy resistance in melanoma treatment, providing valuable insights into navigating challenges and its impact on treatment decisions.

Dozens of students from New York have been named semifinalists in the country’s oldest and most prestigious science and math competition for high school seniors.The Society for Science announced the top 300 scholars in the Regeneron Scienc…

Dozens of students from New York have been named semifinalists in the country’s oldest and most prestigious science and math competition for high school seniors.The Society for Science announced the top 300 scholars in the Regeneron Scienc…

Dozens of students from New York have been named semifinalists in the country’s oldest and most prestigious science and math competition for high school seniors.The Society for Science announced the top 300 scholars in the Regeneron Scienc…

Nikhil Khushalani, MD, provides a thorough exploration of the current treatment landscape in adjuvant therapy for melanoma, presenting insights into advancing strategies and developments in the field, while also discussing key findings from the Checkmate-238 and KEYNOTE-054 trials.

Nikhil Khushalani, MD, delves into the role of combination immunotherapy strategies for melanoma in the adjuvant setting, providing insights into the specific details and outcomes of the IMMUNED trial.